|
Dr. Elizabeth Nabel's stock sales have infuriated a number of Brigham and Women’s employees
|
|
The head of Brigham and Women’s Hospital sold nearly $2 million worth of Moderna stock in May, just as the institution she led was preparing cost-cutting due to COVID-19, bringing her total earnings from the biotech company to $8.5 million this year.
Nabel resigned from the Cambridge biotech’s board of directors Thursday amid concerns that her position there might conflict with the hospital’s role in a large study of the vaccine.
Read the full story.
Brigham president resigns from Moderna board after conflict of interest questions raised
|
|
|
|
|
We have lots of e-mail newsletters on a variety of topics, including news, politics, business, sports, lifestyle, and more. They're free, and it's easy to subscribe. Here's a complete list.
|
|
|
|
